Breaking News, Promotions & Moves

Evotec CEO Takes Leave of Absence

Dohrmann, Bond temporarily take over

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Werner Lanthaler, chief executive officer of Evotec, will temporarily stand down from his role due to health reasons. Dr. Cord Dohrmann, chief scientific officer and Colin Bond, chief financial officer, will lead the company in Dr. Lanthaler’s absence....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters